@article{6a184acd7ef6446f9117b434b0125425,
title = "A pragmatic approach to simplifying inhaler therapy for COPD",
keywords = "Administration, Inhalation, Adrenal Cortex Hormones/administration & dosage, Adrenergic beta-Agonists/administration & dosage, Bronchodilator Agents/administration & dosage, Clinical Decision-Making, Disease Progression, Drug Combinations, Humans, Metered Dose Inhalers, Muscarinic Antagonists/administration & dosage, Practice Guidelines as Topic, Pulmonary Disease, Chronic Obstructive/drug therapy, Symptom Assessment",
author = "Brian Lipworth and Sunny Jabbal",
note = "BL reports personal fees from Cipla, Dr Reddy's Laboratories, Boehringer Ingelheim, Chiesi Farmaceutici, Meda Pharmaceuticals, and Teva Pharmaceutical Industries; reports grants from Janssen, AstraZeneca, Roche, Chiesi Farmaceutici, Meda Pharmaceuticals, and Teva Pharmaceutical Industries, and grants from Sanofi outside of the submitted work; has received support to attend educational meetings from Napp, Boehringer Ingelheim, and Teva Pharmaceutical Industries; and BL's son is an employee of Boehringer Ingelheim. SJ reports personal fees from Napp, Pfizer, Chiesi Farmaceutici, and AstraZeneca; and reports support to attend educational meetings from Napp, Teva Pharmaceutical Industries, Chiesi Farmaceutici, and AstraZeneca.",
year = "2017",
month = sep,
doi = "10.1016/S2213-2600(17)30264-3",
language = "English",
volume = "5",
pages = "679--681",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier",
number = "9",
}